Financials

  • Market Capitalization 38.26 M
  • Employee 5
  • Founded 1979
  • CEO N/A
  • Website www.dyadic.com
  • Headquarter Delaware, United States
  • FIGI BBG000L276R1
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-4.09
Rapporto prezzo/fatturato
9.92

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4397
GRCE
Grace Therapeutics, Inc. - Common Stock
2.46 USD+1.23%-0.40%+11.82%-38.19%40.03 M USD
4403
VERU
Veru Inc. - Common Stock
2.35 USD-8.20%-17.25%-22.19%-1.67%37.72 M USD
4411
ACTU
Actuate Therapeutics, Inc. - Common stock
1.68 USD+12.00%+15.86%-21.50%-58.82%40.20 M USD
4421
ESLA
Estrella Immunopharma, Inc. - Common Stock
0.82 USD-6.82%-12.77%-26.13%-3.53%35.29 M USD

Notizie